Transcriptional activity of the 5′-flanking region of the thyroid transcription factor-1 gene in human thyroid cell lines by Yamada, Hiroya et al.
Transcriptional activity of the 5’-flanking region of the thyroid transcription









1Department of Laboratory Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
2Division of Health Sciences, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
3Kuma Hospital, Chuo-ku, Kobe, Hyogo, Japan.
Abstract
Thyroid transcription factor-1 (TTF-1, NKX2-1) is a homeodomain-containing transcriptional factor that binds to and
activates the promoters of thyroid and lung-specific genes, such as thyroglobulin, thyroid peroxidase, and thyroid
stimulating hormone receptor. TTF-1 is known to play a key role in the development of the thyroid. However, the pre-
cise mechanism of TTF-1 gene transcription in human thyroid cells has not been studied. The expression of
transcriptional activity in various lengths of the 5’-flanking region of the human TTF -1 gene was studied in TTF-1
positive and negative human thyroid cell lines. Increased transcriptional activity was observed in thyroid cell lines
containing plasmids that coded for a sequence proximal to the transcription start site of exon 1 of the TTF-1 gene.
However, we did not observe any difference in promoter activity in the region up to -2.6 kb from the proximal tran-
scription startsiteoftheTTF-1genebetween TTF-1positive andnegative cells.Theseresultssuggestthattheproxi-
mal 5’-flanking region of the human TTF -1 gene does not contain sufficient cis-active regulatory information to direct
gene expression in thyroid cells,and that other cis- or trans-acting factors participate in the thyroid specific gene ex-
pression of TTF-1.
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Introduction
Thyroid transcription factor-1 (TTF-1, NKX2-1)i sa
homeodomain-containing transcriptional factor that binds
toandactivatesthepromotersofthyroidandlungepithelial
genes. TTF-1 expression becomes detectable in the thyroid
primordiumasitbeginstomigratecaudallyfromjustabove
the aortic sac in E9-E10 embryos (Lazzaro et al., 1991).
Thus, the expression of TTF-1 is regarded as a potentially
useful marker for selecting and identifying fetal thyroid
cells in studies analyzing the regeneration of thyroid folli-
cular cells or thyroid cancer stem cells (Takano, 2007;
Klonisch et al., 2009). Furthermore, it is necessary for the
activation of thyroid specific genes, such as thyroglobulin,
thyroid peroxidase, and thyroid-stimulating hormone re-
ceptor. The absence of wild type TTF-1 activity results in
extensive phenotypic and functional abnormalities in the
thyroid (Vliet, 2003).
In cell lines derived from the lung, a proximal 5’-
flanking region of the TTF-1 gene of 2.7 kb in length has
been reported to show strong transcriptional activity (Ikeda
et al., 1995). Even though TTF-1 plays a key role in early
thyroid development, the precise mechanism of TTF-1
gene transcription in thyroid cells remains mostly un-
known. Pan et al. (2004) introduced DNA from the TTF-1
5’ DNA flanking region to induce direct expression of
LacZ in transgenic mice during embryonic development.
ThesetransgenicmiceexpressedLacZinthelungbutnotin
the thyroid. These results indicate that, at least in mice, the
regulatory elements that are essential for TTF-1 expression
in thyroid cells are located in the genomic regions outside
of the TTF-1 5’-flanking region. Nakazato et al. (1997) an-
alyzed the transcriptional activity of the rat TTF-1 gene in
the FRTL-5 rat thyroid cell line. They observed strong
transcriptionalactivityinthe5’-flankingregionfrom-2507
to -1892 but not in the region from -2021 to -1892 and con-
cluded that the sequence from -2507 to -2021 of the rat
TTF-1 gene exhibits tissue-selective promoter activity.
Furthermore, Oguchi and Kimura (1998) transfected rat
TTF-1genesequencesofvariouslengthsintoFRTL-5cells
and concluded that a -1.94 kb upstream sequence is re-
quired for maximal promoter activity. The results in these
three studies differed, and no study using human thyroid
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Research Articlecells has been published, probably because until recently
there were no known human thyroid cell lines that were
able to abundantly express TTF-1.
Inarecentstudywefoundtwoanaplasticthyroidcar-
cinoma (ATC)-derived cell lines, TCO-1 and 8505C, that
expressedTTF-1mRNA(Takanoetal.,2007).Thus,inthe
present paper, we investigated TTF-1 5’-flanking region
transcriptionalactivityinTCO-1and8505Ccellsandcom-
pared the results with those for other ATC cell lines, viz.
8305C and SW571, which do not express TTF-1 mRNA.
Materials and Methods
Cloning of the 5’-flanking region of the human TTF-1
gene and construction of TTF-1 reporter plasmid
A5’-upstreamregionoftheTTF-1genewasamplified
fromhumangenomicDNAusingthepolymerasechainreac-
tion (PCR), as described previously (Takano et al., 2008).
The PCR products were sub-cloned into a pGL4 vector
(Promega, Tokyo, Japan) containing a luciferase reporter
gene. According to previous studies, the position of the first
ATGinthesecondexonwasdesignatedaszero(Oguchiand
Kimura, 1998). The human TTF-1 gene has two major tran-
scriptionstartsites.Oneisupstreamofthefirstexon,andthe
other is localized in the first intron (Hamdan et al., 1998).
The DNA fragments were designed to cover these regions.
TheclonedfragmentsTA1-5andTB2-5coveredthefollow-
ing regions: -210 to -1, -552 to -1, -1272 to -1, -2110 to -1,
and -2744 to -1 and -522 to -179, -1272 to -179, -2110 to
-179, and -2744 to -179, respectively.
Cell culture
Four cell lines derived from human ATC namely
TCO-1, 8505C, SW571, and 8305C, were cultured in
RPML-1640 with 10% fetal bovine serum (Invitrogen, To-
kyo, Japan) at 37 °C in 5% CO2. HepG2 cells derived from
humanliverwereculturedinDMEMwith10%fetalbovine
serum (Invitrogen) at 37 °C in 5% CO2. All cell lines were
provided by the Human Science Research Resource Bank
(Osaka, Japan).
Transfection and luciferase assay
24 h before transfection, the cells were plated in a
24-well plate at a density of 200,000 cells/well and allowed
to grow under normal culture conditions. A promoter-less
pGL4 vector was used as control. The plasmid pRL-CMV
(Promega) containing the Renilla firefly reporter gene was
co-transfected into all cells to normalize the results. 400 ng
of pGL4-reporter vector containing one of the fragments of
the TTF-1 upstream genomic sequence and 5 ng of the
pRL-CMV vector were co-transfected into each cell using
1.2 L of Lipofectamine 2000 (Invitrogen), and the cells
were cultured for 48 h. Relative luciferase activity in each
celllysatewasmeasuredwiththeDual-LuciferaseReporter
Assay System (Promega), according to the manufacturer’s
protocol.
Extraction of RNA from thyroid tissues and cells
Tissue samples from three normal thyroid tissues
from the lobe contralateral to a carcinoma were collected
during surgery, after we had obtained informed consent
from each patient. The study protocol was approved by the
ethics committee of Kuma Hospital. Tissues were frozen in
liquid nitrogen immediately after resection. Total RNA of
thesetissuesandcelllineswasextractedasdescribedprevi-
ously (Yamada et al., 2009).
Reverse transcription
Reverse transcription (RT) was performed using 1 g
of total RNA in an RT mixture containing 50 mM Tris-HCl
(pH 8.3), 75 mM KCl, 10 mM dithiothreitol, 3 mM MgCl2,
0.5 mM deoxynucleotide triphosphates (dNTP) (Takara,
Shiga, Japan), 200 U MMLV reverse transcriptase (Invi-
trogen), 2 U/L RNase inhibitor (Takara), and 2.5 Mo f
random hexamers (Takara) in a total volume of 20 La t
42 °C for 60 min.
Real-time quantitative PCR
Thereal-timequantitativePCRusingTaqManprobes
was performed using an ABI PRISM 7700 Sequence De-
tection System (Applied Biosystems, Foster City, CA
USA), as previously described (Takano et al., 1999) using
1LoffirststrandcDNA.Thesequenceofthetwoprimers
and the TaqMan probe used for quantification of TTF-1
mRNA (TITF-1, GenBank BC006221) were:
TTF1F (0.5 M) 5’-TCCAGAACCACCGCTACA-
3’ (bases 746-763),
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Table 1 - Summary of the transcriptional activity of the 5’ flanking region of the TTF-1 gene described in the present and previous studies.
Sequence Target of transfection Specific transcriptional activity Reference
Human Human lung adenocarcinoma cell line + Hamdan, Ikeda
Human Mouse lung cell line + Ikeda
Rat Rat thyroid cell line + Nakazato, Oguchi
Mouse Lung (transgenic mouse) + Pan
Mouse Thyroid (transgenic mouse) - Pan
Human Human thyroid anaplastic carcinoma cell line - Present studyTTF1R (0.5 M) 5’- ACGGTTTGCCGTCTTTCA
C-3’ (bases 928-910),
and TTF1-TM (140 nM) 5’-FAM-ACTGCTGCTGA
GCCTGTTGCTGC -TAMRA-3’ (bases 879-853).
-actin (ACTB) mRNA (GenBank X00351) was used
as endogenous control.
The sequence of the two primers and of the TaqMan
probe used for ACTB mRNA quantification were:
ACF (0.5 M) 5’-TGGACATCCGCAAAGACCTG
-3’ (bases 901-920),
ACR (0.5 M) 5’-CCGATCCACACGGAGTACT
T-3’ (bases 1066-1047),
and AC-TM (140 nM) 5’-FAM-CACCACCATGTA
CCCTGGCATTGCC-TAMRA-3’ (bases 947-971).
All primers and probes were purchased from Operon
Biotechnologies (Tokyo, Japan). The conditions for
TaqMan PCR were: 95 °C for 10 min and 40 cycles of
95 °C for 15 s and 60 °C for 1 min. Recombinant pGEM
T-vectors (Promega, Tokyo, Japan) containing either
TTF-1 or -actin cDNA were constructed by PCR-cloning,
using the same sets of primers as those used for RT-PCR,
and then used as standard samples. The amplification plots
were used to determine the threshold cycle (CT). The initial
mRNA copy number was calculated by plotting CT against
input target quantity.
Sequence analysis of the 5’-flanking region of the
human TTF-1 gene
Genomic DNA was isolated using a QIAamp DNA
Mini Kit (Qiagen, Tokyo, Japan) from five cell lines. The
5’-upstream region of the TTF-1 gene was amplified by
PCR, and the PCR products were sub-cloned into a
pGEM-Easy T vector. The cloned fragments covered the
region from -2744 to -1. The purified fragments were se-
quenced using a BigDye Terminator Cycle Sequencing FS
Ready Reaction Kit with an ABI PRISM 310 Genetic Ana-
lyzer (Applied Biosystems, Tokyo, Japan). At least three
clones were analyzed for each cell line.
Results
The expression of TTF-1 mRNA was observed in all
threenormalthyroidtissuesamples,aswellasinthe8505C
and TCO-1 cells. In contrast, the 8305C, SW571, and
HepG2 cells showed almost no TTF-1 transcripts
(Figure 1). When analyzing the sequence of the 5’-
upstream region of the TTF-1 gene in each cell line, we did
not find any mutations or deletions in this region in any of
the five cell lines (data not shown).
In the experiments using TA1-5 plasmids, the trans-
criptional activity of one of the TTF-1 positive cell lines,
8505C, was greatly increased by TA1 compared with the
activity observed in the TTF-1 negative cell lines SW571
and 8305C. Nevertheless, another TTF-1 positive cell line,
TCO-1, did not demonstrate a clear increase in TTF-1 tran-
scription (Figure 2). Thus, there was no plasmid by which
TTF-1 positive and negative cell lines would be distin-
guishable in terms of transcriptional activity. In the thyroid
cell lines, a clear increase in transcriptional activity was
only observed for TA1-3.
Since TA1, which contained a sequence downstream
of the proximal transcription start site, but not TA2 showed
extremely high transcriptional activity in 8505C, we con-
structed another set of plasmids, TB2-TB5, which did not
8 TTF-1 gene in human thyroid cell lines
Figure 1 - Expression levels of TTF-1 mRNA relative to -actin mRNA.




The base numbers are based on the position of the first ATG in the second
exon being 0. Different lengths of DNA from the 5’ flanking region of the
human TTF-1 gene were attached to a luciferase reporter plasmid and
transfected into five cell lines. Relative luciferase activity obtained with
thepromoterlesspGL4vectorwasarbitrarilysetas1.Valuesareshownas
the mean  SD of triplicate assays.possess this sequence to test whether this modification
would alter the results. When we used these plasmids, a
clear decrease in transcriptional activity was observed in
8505C cells. These results indicated that the high trans-
criptional activity observed in 8505C cells following the
addition of TA1-5 plasmids was mainly caused by the de-
letedsequenceinexon2(Figure3).Noplasmidwasableto
distinguish the TTF-1 positive cell lines from the TTF-1
negative ones in terms of transcriptional activity. Amongst
the thyroid cell lines, TB4 and TB5 tended to show weaker
transcriptional activity than TB2 and TB3.
Discussion
This is the first report analyzing the transcriptional
activity of the human TTF-1 5’-flanking regions in human
thyroid cell lines. The results of previous and the present
study on transcriptional activity of the TTF-1 5’- flanking
sequence are summarized in Table 1. Although with TA1,
one TTF-1 positive cell line, 8505C, showed high trans-
criptional activity, no increase was observed in another
TTF-1 positive cell line, TCO1, or when longer sequences
were used, such as TA2-5. Thus, we conclude that no pro-
moter activity was observed that clearly differed between
TTF-1positiveandnegativecellsintheregionupto-2.6kb
fromtheproximaltranscriptionstartsiteoftheTTF-1gene.
Our results present a clear discrepancy from those of two
previous studies using the FRTL-5 rat thyroid cell line,
which showed high promoter activity in this region (Na-
kazato et al., 1997; Oguchi and Kimura, 1998). These stud-
ies presented different results regarding the region of the
TTF-1genethatshowedthehighestpromoteractivity.This
discrepancy may partly be due to the use of FRTL-5 cells,
as this cell line frequently exhibits clonal heterogeneity
(Jeker et al., 1999). Our study agrees with a previous report
that used transgenic mice, showing that regulatory ele-
ments that are essential for TTF-1 expression in thyroid
cells exist in genomic regions outside of the TTF-1 5’-flan-
king region (Pan et al., 2004).
Before drawing this conclusion, further studies are
needed. First, even though we confirmed the abundant ex-
pression of TTF-1 mRNA in TCO-1 and 8505C cells, the
expression levels of TTF-1 were much lower than those
seen in normal thyroid tissues. This may be due to the fact
that TTF-1 expressing thyroid cell lines contain a consider-
able number of TTF-1 negative cells (Zito et al., 2009). We
therefore need to clarify whether such cells may have af-
fected our results. Second, we sequenced the TTF-1 5’-
flanking region in both TTF-1 positive and negative cell
lines and confirmed that there were no mutations or dele-
tions. However, besides mutation analysis, the possibility
of methylation of the TTF-1 promoter should be investi-
gated because it can cause epigenetic silencing (Kondo et
al., 2009).
In thyroid cell lines we observed higher trans-
criptional activity in cells containing plasmids that code for
asequenceproximaltothetranscriptionstartsiteofexon1.
Some transcription factors that interact with this region
may enhance transcription, whereas factors that interact
withthedistalregionmaynegativelyregulatetranscription,
although these effects are probably not restricted to TTF-1
positive cells.
Our results showed a striking difference from studies
using TTF-1 positive lung cell lines, which showed strong
transcriptionalactivitywhenthecellsweretransfectedwith
plasmids similar to ours (Ikeda et al., 1995; Hamdan et al.,
1998). A further comparison of the transcriptional activity
of the TTF-1 gene between thyroid- and lung-derived cell
lines may clarify the factors that negatively regulate TTF-1
transcription in thyroid cells.
In conclusion, we did not observe differences in pro-
moter activity in a region up to -2.6 kb from the proximal
transcription start site of the TTF-1 gene between TTF-1
positive and negative human thyroid cells. These results
suggest that the 5’-flanking region of the human TTF -1
gene does not contain sufficient cis-active regulatory infor-
mation to direct gene expression in human thyroid cells.
Acknowledgments
This research was supported by the Ministry of Edu-
cation, Culture, Sports, Science, and Technology of Japan;
a Grant-in-Aid for Scientific Research (C, 2008-2010, No.
20590570) and a Research Grant from the Princess Taka-
matsu Cancer Research Fund (04-23606).
Yamada et al. 9
Figure3-SchematicdiagramoftheTTF-1promoterluciferaseconstructs
and the transcriptional activity of the TTF-1 5’ flanking sequences TB2-5.
Thehatchedboxesrepresentexonswhiletheopenboxesrepresentintrons.
Base numbers are in relation to the position of the first ATG codon in the
second exon, this being set as 0. The transcription region after the proxi-
mal transcription start site has been deleted from TA2-5. The resultant
plasmidsweretransfectedintofivecelllines.Therelativeluciferaseactiv-
ity obtained with the promoterless pGL4 vector was arbitrarily set as 1.
The values are shown as the mean  SD of triplicate assays.References
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